Details for New Drug Application (NDA): 088441
✉ Email this page to a colleague
NDA 088441 describes URECHOLINE, which is a drug marketed by Teva Branded Pharm and Odyssey Pharms and is included in five NDAs. Additional details are available on the URECHOLINE profile page.
The generic ingredient in URECHOLINE is bethanechol chloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
The generic ingredient in URECHOLINE is bethanechol chloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 088441
| Tradename: | URECHOLINE |
| Applicant: | Odyssey Pharms |
| Ingredient: | bethanechol chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088441
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | May 29, 1984 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
